- Home
- |
- About Us
- |
- What we do
- |
- Innovation
- |
- Media
- |
- Resources
- |
- Contact Us
- |
- Why Now
- |
- Blog
Monday, July 16, 2012
Free Podcast: Improve Patient Adherence with Patient Support Programs
In the latest podcast, I share my thoughts on improving patient adherence through patient support programs. Specifically, I discuss how patient support programs contribute to higher patient compliance rates, better patient health, lower healthcare expenses, and improved patient retention.
If you would like to listen to this podcast, please click to download it now. After you listen to the podcast, let me know what you think of it—is it helpful? Are you currently providing patient support programs? If so, please share your experiences and insights on these programs. This area is evolving quickly, and we can all learn from one another.
We also recently published a free white paper titled “Increase Patient Adherence and Do More with Less”. We encourage you to download this companion piece to the podcast.
View Full Blog
View website for Tunstall AMAC Life Sciences
Thursday, July 12, 2012
Fact: Healthcare Is Changing
Efforts to reform healthcare are moving forward as it is clear that as a nation we must decrease healthcare costs. Right now there are more questions than answers about the impact of the Affordable Care Act (ACA) that the US Supreme Court recently upheld. One thing is clear—the US healthcare system is changing. Below are my thoughts on three key areas the life science industry must prepare for.
Articulate the value of your product.
Implementation tips...
1) Adjust your forecasts
2) Begin working on how to articulate the value of your product (see above for insights)
Implementation tips...
1) Plan and implement programs that support patients on their treatment journey.
2) Understand the barriers patients face in remaining adherent and compliant with therapy.
3) Develop and implement patient support programs that are a resource and guide for patients during their treatment journey. This can include offering access to healthcare-trained representatives for questions or providing educational materials to help patients continue with treatment.
The June 2012 issue of PharmaVOICE magazine has an article on healthcare reform and the potential impacts of it on the life science industry. If you are interested in additional perspectives on the impact of healthcare reform you can access the article here.
I’d like to hear from you. How are you preparing for the impact of the ACA? What areas have you identified as opportunities? What kinds of initiatives and programs are you planning? Please join the conversation and share your thoughts, challenges, and questions on the ACA implementation. We can all learn from each other.
Articulate the value of your product.
Conventional end points of safety, efficacy, and quality of life are no longer sufficient. Be prepared to demonstrate cost-effectiveness or cost-avoidance.
Implementation tips...
1) Work collaboratively with your colleagues in marketing, managed care marketing, pharmacoeconomics, clinical affairs, medical affairs, and regulatory to understand the data that is desired by various stakeholders when they are determining if a product is valuable or not. Develop plans to obtain the needed data.
2) Determine which patients are most likely to benefit from your product. Communicate to healthcare providers the patients that are most likely to benefit from treatment. Additionally, assist with screening and referring appropriate patients to local physicians or study sites.
1) Work collaboratively with your colleagues in marketing, managed care marketing, pharmacoeconomics, clinical affairs, medical affairs, and regulatory to understand the data that is desired by various stakeholders when they are determining if a product is valuable or not. Develop plans to obtain the needed data.
2) Determine which patients are most likely to benefit from your product. Communicate to healthcare providers the patients that are most likely to benefit from treatment. Additionally, assist with screening and referring appropriate patients to local physicians or study sites.
Plan for government rebate plans and pricing controls.
If your treatment is expensive, be prepared for limitations on its use compared to less expensive alternatives.
Implementation tips...
1) Adjust your forecasts
2) Begin working on how to articulate the value of your product (see above for insights)
Provide programs that enhance outcomes for individual patients.
Shift your focus to taking care of patients and improving their outcomes. Patients will stay on treatment and future healthcare expenses resulting from patient non-adherence will decrease.
Implementation tips...
1) Plan and implement programs that support patients on their treatment journey.
2) Understand the barriers patients face in remaining adherent and compliant with therapy.
3) Develop and implement patient support programs that are a resource and guide for patients during their treatment journey. This can include offering access to healthcare-trained representatives for questions or providing educational materials to help patients continue with treatment.
The June 2012 issue of PharmaVOICE magazine has an article on healthcare reform and the potential impacts of it on the life science industry. If you are interested in additional perspectives on the impact of healthcare reform you can access the article here.
I’d like to hear from you. How are you preparing for the impact of the ACA? What areas have you identified as opportunities? What kinds of initiatives and programs are you planning? Please join the conversation and share your thoughts, challenges, and questions on the ACA implementation. We can all learn from each other.
Friday, July 6, 2012
White Paper - Do More with Less—Invest in Patient and Caregiver Support Programs
A successful model |
We have seen adherence rates increase by
10% to 15% after a patient and caregiver support program is implemented and
maintained for one year. Increasing patient adherence is a win:win:win
situation. Patients gain better health and enhanced quality of life, payers
decrease expenses treating future healthcare issues that arise from
non-compliance, and life science companies retain patients on therapy.
In our patient and caregiver support programs we have seen
significant demand from patients for personalized experiences and information. The
days of developing and disseminating materials for the masses are ending.
Rather, patients want information specific to them, their condition, and needs.
Opportunities for providing patients with personalized
information abound, and I have recently published a white paper on how to
develop successful patient and caregiver support programs, as well as emerging
trends being used to deliver customized and personalized experiences for
patients. Patient and caregiver support programs can help life science companies
retain patients on treatment and create real value for patients, healthcare
providers, and payers.
If you’d like a copy of the white paper titled “Increase
Patient Adherence and Do More with Less,” please click to download it. Please let me know what you think of
this latest white paper—is it helpful or not? Also, let me know what areas you’d
like to see more information and recommendations on.
View Full Blog
View website for Tunstall AMAC Life Sciences
View Full Blog
View website for Tunstall AMAC Life Sciences
Subscribe to:
Posts (Atom)